Covetrus is a health information services business based in the US. Covetrus stocks (CVET.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $25.52 – an increase of 1.7% over the previous week. Covetrus employs 5,275 staff and has a trailing 12-month revenue of around $4.6 billion.
Finder's Pick for
Free Trades
Finder's Pick for
Beginners
Finder's Pick for
Savvy Investors
Finder's Pick for
Students
| Latest market close | $16.78 |
|---|---|
| 52-week range | $15.80 - $40.78 |
| 50-day moving average | $18.32 |
| 200-day moving average | $22.92 |
| Wall St. target price | $26.00 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | $-0.41 |
Note: The dollar amounts in the table below are in Canadian dollars.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Historical closes compared with the close of $16.78 from 2022-01-19
| 1 week (2022-01-14) | 3.13% |
|---|---|
| 1 month (2021-12-21) | -8.21% |
| 3 months (2021-10-21) | -17.34% |
| 6 months (2021-07-21) | -33.52% |
| 1 year (2021-01-21) | -57.49% |
|---|---|
| 2 years (2020-01-21) | 11.35% |
| 3 years (2019-01-17) | N/A |
| 5 years (2017-01-17) | N/A |
Valuing Covetrus stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Covetrus's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Covetrus's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.3326. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Covetrus's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Covetrus's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $158 million.
The EBITDA is a measure of a Covetrus's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $4.6 billion |
|---|---|
| Gross profit TTM | $798 million |
| Return on assets TTM | -0.22% |
| Return on equity TTM | -3.55% |
| Profit margin | -1.2% |
| Book value | $10.91 |
| Market capitalisation | $2.2 billion |
TTM: trailing 12 months
We're not expecting Covetrus to pay a dividend over the next 12 months.
Over the last 12 months, Covetrus's shares have ranged in value from as little as $15.8 up to $40.775. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Covetrus's is 2.1112. This would suggest that Covetrus's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Covetrus, Inc. , together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers. The company also offers value-added solutions that include, inventory management and e-commerce, as well as continuing education services for practitioners. In addition, it provides practice management software systems for veterinary practitioners and animal-health clinics, client communication services, reminders, data backup services, and hardware sales and support services. Further, the company engages in the distribution of finished goods pharmacy and specialty pharmaceutical compounding products, as well as shipping, manufacturer incentives, service fees, and data integration and support services. It serves animal-health and veterinary practices, and clinics in the companion-animal and equine markets primarily in North America, Europe, and the Asia Pacific.
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
Read more…
Steps to owning and managing Aritzia (ATZ) stock, with 24-hour and historical pricing before you buy.
Get low fees and access many different types of accounts, platforms and investments with this reputable online broker.
Read our expert analysis on Kusama and how the token will perform in the future.
This guide provides step-by-step instructions on how to buy The Sandbox, lists some exchanges where you can get it and provides daily price data on SAND.
We’ve rounded up stats on some of the most popular COVID testing stocks, along with information on how they compare and how to invest.
This guide explores the different ways of buying Shiba Inu on a cryptocurrency exchange as well as where you should store your cryptocurrency.
This guide provides step-by-step instructions on how to buy Baby Doge Coin, lists some exchanges where you can get it and provides daily price data on BABYDOGE.
This guide provides step-by-step instructions on how to buy Pendle, lists some exchanges where you can get it and provides daily price data on PENDLE.
This guide provides step-by-step instructions on how to buy Hempcoin, lists some exchanges where you can get it and provides daily price data on THC.
This guide provides step-by-step instructions on how to buy The ChampCoin, lists some exchanges where you can get it and provides daily price data on TCC.
